VC-backed Eloxx Pharmaceuticals names CFO
Israel and Waltham, Massachusetts-based Eloxx Pharmaceuticals Ltd, a developer of treatments that focus on genetic diseases caused by nonsense mutations, has appointed Gregory Weaver as chief financial officer. He is the former CFO at Prometic Life Sciences. The investors included Korea Investment Partners, DSC Investments, Pontifax Venture Capital and Quark Venture.
26 September 2017•3 mins read
